Why the US Dominates the Psychedelic Therapeutics Market: Clinical Trials, Investments, and Policy Shifts
The global healthcare landscape is experiencing a transformative shift with growing interest in innovative mental health treatment approaches. Psychedelic-assisted therapies, involving compounds such as Psilocybin and MDMA, are gaining recognition for their potential to address treatment-resistant psychiatric conditions. Increasing clinical validation, regulatory progress, and rising mental...